Literature DB >> 4178003

Transient and permanent deafness following treatment with ethacrynic acid in renal failure.

V K Pillay, F D Schwartz, K Aimi, R M Kark.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4178003     DOI: 10.1016/s0140-6736(69)91092-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  The treatment of diabetic kidney disease.

Authors:  F C Goetz; C M Kjellstrand
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

3.  Differential effects of ouabain and ethacrynic acid on the labyrinthine potentials.

Authors:  P M Sellick; B M Johnstone
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

Review 4.  Diuretics. II. Clinical considerations.

Authors:  J L Anderton; P Kincaid-Smith
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  [Hearing loss induced by the use of high doses of furosemide in the treatment of uremia].

Authors:  A Heidland; M E Wigand
Journal:  Klin Wochenschr       Date:  1970-09-01

6.  [Histochemical changes in guinea pig cochlea under the influence of diuretics].

Authors:  J Haubrich; W Schätzle
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1970

7.  [Histochemical changes in guinea pig cochlea under the experimental influence of the diuretic hydromidin (ethacrynic acid)].

Authors:  J Haubrich; W Schätzle
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1971

8.  Furosemide and ethacrynic acid in acute tubular necrosis.

Authors:  D W Nierenberg
Journal:  West J Med       Date:  1980-08

9.  Drug-induced ototoxicity.

Authors:  R E Brummett
Journal:  Drugs       Date:  1980-06       Impact factor: 9.546

10.  Ethacrynic acid. Effects on the cochlear potentials in normal and high blood oxygen.

Authors:  J Prazma; J B Pecorak
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.